In vitro activity of telithromycin and quinupristin/dalfopristin against methicillin-resistant coagulase-negative staphylococci with defined resistance genotypes

Folia Microbiologica

Volumn 52, Issue 6, 2007, Pages 593-599

  Novotna G ^a   Spizek J ^a   Janata, J ^a  

^a INSTITUTE OF MICROBIOLOGY   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLINDAMYCIN; COAGULASE; DALFOPRISTIN; DALFOPRISTIN PLUS QUINUPRISTIN; ERYTHROMYCIN; KETOLIDE; MACROLIDE; MIKAMYCIN B; QUINUPRISTIN-DALFOPRISTIN; TELITHROMYCIN; UNCLASSIFIED DRUG; VIRGINIAMYCIN;

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG EFFECT; GENETICS; METABOLISM; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; CLINDAMYCIN; COAGULASE; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; KETOLIDES; MACROLIDES; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS; STREPTOGRAMIN A; STREPTOGRAMIN B; VIRGINIAMYCIN;

STAPHYLOCOCCUS; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS HAEMOLYTICUS;

EID: 39449116392     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02932188     Document Type: Article

References (29)

1. ALLIGNET J., AUBER S., MORVAN A., EL SOLH N.: Distribution of genes encoding resistance to streptogramin A and related compounds among staphylococci resistant to these antibiotics. Antimicrob.Agents Chemother. 40, 2523-2528 (1996).
2. BESIER S., HUNFELD K.P., GIESSER I., SCHAFER V., BRADE V., WICHELHAUS T.A.: Selection of ketolide resistance in Staphylococcus aureus. Internat.J.Antimicrob.Agents 22, 87-88 (2003).
3. BONNEFOY A., GIRARD A.M., AGOURIDAS C., CHANTO J.F.: Ketolides lack inducibility properties of MLS(B) resistance phenotype. J.Antimicrob.Chemother. 40, 85-90 (1997).
4. BOZDOGAN B., LECLERCQ R.: Effects of genes encoding resistance to streptogramins A and B on the activity of quinupristin- dalfopristin against Enterococcus faecium. Antimicrob.Agents Chemother. 43, 2720-2725 (1999).
5. CLSI: Performance Standards for Antimicrobial Susceptibility Testing; 17th Informational Supplement M100-S17, pp. 1987-1898. Clinical and Laboratory Standards Institute, Wayne (USA) (2007).
6. DAVIS K.A., CRAWFORD S.A., FIEBELKORN K.R., JORGENSEN J.H.: Induction of telithromycin resistance by erythromycin in isolates of macrolide-resistant Staphylococcus spp. Antimicrob.Agents Chemother. 49, 3059-3061 (2005).
7. DUPUIS M., LECLERCQ R.: Activity of a new oral streptogramin, XRP2868, against Gram-positive cocci harboring various mechanisms of resistance to streptogramins. Antimicrob.Agents Chemother. 50, 237-242 (2006).
8. HAMILTON-MILLER J.M., SHAH S.: Patterns of phenotypic resistance to the macrolide-lincosamide-ketolide-streptogramin group of antibiotics in staphylococci. J.Antimicrob.Chemother 46, 941-949 (2000).
9. HAROCHE J., MORVAN A., DAVI M., ALLIGNET J., BIMET F., EL SOLH N.: Clonal diversity among streptogramin A-resistant Staphylococcus aureus isolates collected in French hospitals. J.Clin.Microbiol. 41, 586-591 (2003).
10. LECLERCQ R., CARLIER C., DUVAL J., COURVALIN P.: Plasmid-mediated resistance to lincomycin by inactivation in Staphylococcus haemolyticus. Antimicrob.Agents Chemother. 28, 421-424 (1985).
11. LINA G., QUAGLIA A., REVERDY M.E., LECLERCQ R., VANDENESCH F., ETIENNE J.: Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob.Agents Chemother. 43, 1062-1066 (1999).
12. LUTHJE P., SCHWARZ S.: Antimicrobial resistance of coagulase-negative staphylococci from bovine subclinical mastitis with particular reference to macrolide-lincosamide resistance phenotypes and genotypes. J.Antimicrob.Chemother. 57, 966-969 (2006).
13. MATSUOKA M., ENDOU K., KOBAYASHI H., INOUE M., NAKAJIMA Y.: A plasmid that encodes three genes for resistance to macrolide antibiotics in Staphylococcus aureus. FEMS Microbiol.Lett. 167, 221-227 (1998).
14. MATSUOKA M., JANOSI L., ENDOU K., NAKAJIMA Y.: Cloning and sequences of inducible and constitutive macrolide resistance genes in Staphylococcus aureus that correspond to an ABC transporter. FEMS Microbiol.Lett. 181, 91-100 (1999).
15. LC from Staphylococcus haemolyticus with shifted substrate specificity towards lincosamides. Antimicrob.Agents Chemother. 50, 4070-4076 (2006).
16. NOVOTNÁ G., ADÁMKOVÁ V., JANATA J., MELIER O., SPÍŽEK J.: Prevalence of resistance mechanisms against macrolides and lincosamides in methicillin-resistant coagulase-negative staphylococci in the Czech Republic and occurrence of an undefined mechanism of resistance to lincosamides. Antimicrob.Agents Chemother. 49, 3586-3589 (2005).
17. PETINAKI E., SPILIOPOULOU I., MANIATI M., MANIATIS A.N.: Emergence of Staphylococcus hominis strains expressing low-level resistance to quinupristin/dalfopristin in Greece. J.Antimicrob.Chemother. 55, 811-812 (2005).
18. REYNOLDS E., COVE J.H.: Enhanced resistance to erythromycin is conferred by the enterococcal msrC determinant in Staphylococcus aureus. J.Antimicrob.Chemother. 55, 260-264 (2005).
19. ROSS J.L, EADY E.A., COVE J.H., CUNLIFFE W.J., BAUMBERG S., WOOTTON J.C.: Inducible erythromycin resistance in staphylococci is encoded by a member of the ATP-binding transport super-gene family. Mol.Microbiol. 4, 1207-1214 (1990).
20. ROSS J.I., EADY E.A., COVE J.H., BAUMBERG S.: Minimal functional system required for expression of erythromycin resistance by msrA in Staphylococcus aureus RN4220. Gene 183, 143-148 (1996).
21. SADER H.S., STREIT J.M., PRITSCHE T.R., JONES R.N.: Antimicrobial susceptibility of Gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004). Clin.Microbiol.Infect. 12, 844-852 (2006).
22. SCHMITZ F.J., PETRIDOU J., ASTFALK N., KOHRER K., SCHEURING S., SCHWARZ S.: Molecular analysis of constitutively expressed erm(C) genes selected in vitro by incubation in the presence of the non-inducers quinupristin, telithromycin, or ABT-773. Microb.Drug Resist. 8, 171-177 (2002a).
23. SCHMITZ F.J., PETRIDOU J., MILATOVIC D., VERHOEF J., FLUIT A.C., SCHWARZ S.: In vitro activity of new ketolides against macrolide-susceptible and -resistant Staphylococcus aureus isolates with defined resistance gene status. J.Antimicrob.Chemother. 49, 580-582 (2002b).
24. SCHMITZ F.J., SCHWARZ S., MILATOVIC D., VERHOEF J., FLUIT A.C.: In vitro activities of the ketolides ABT-773 and telithromycin and of three macrolides against genetically characterized isolates of Streptococcus pneumoniae, Streptococcus pyogenes, Haemophilus influenzae and Moraxella catarrhalis. J.Antimicrob.Chemother. 50, 145-148 (2002c).
25. SCHNELLMANN C., GERBER V., ROSSANO A., JAQUIER V., PANCHAUD Y., DOHERR M.G., THOMANN A., STRAUB R., PERRETEN V.: Presence of new mecA and mph(C) variants conferring antibiotic resistance in Staphylococcus spp. isolated from the skin of horses before and after clinic admission. J.Clin.Microbiol. 44, 4444-4454 (2006).
26. URBÁŠKOVÁ P.: Resistance of Bacteria toward Antibiotics - Selected Methods. (In Czech) Trios, Prague 1998.
27. WEISBLUM B., DEMOHN V.: Erythromycin-inducible resistance in Staphylococcus aureus: survey of antibiotic classes involved. J.Bacteriol. 98, 447-452 (1969).
28. WONDRACK L., MASSA M., YANG B. V., SUTCLIFFE J.: Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob.Agents Chemother. 40, 992-998 (1996).
29. ZARROUK V., BOZDOGAN B., LECLERCQ R., GARRY L., CARBON C., FANTIN B.: Influence of resistance to streptogramin A type antibiotics on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis due to Staphylococcus aureus. Antimicrob.Agents Chemother. 44, 1168-1173 (2000).